Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease
Year: 2014
Type: article
Abstract: Alpha-synuclein (aSyn) is the main component of proteinaceous inclusions known as Lewy bodies (LBs), the typical pathological hallmark of Parkinson's disease (PD) and other synucleinopathies. Although aSyn is phosphorylated at low levels under physiological conditions, it is estimated that ∼ 90% of aSyn in LBs is phosphorylated at S129 (pS129). Nevertheless, the significance of pS129 in the biology of aSyn and in PD pathogenesis is still controversial. Here, we harnessed the power of budding yeast in order to assess the implications of phosphorylation on aSyn cytotoxicity, aggregation and sub-cellular distribution. We found that aSyn is phosphorylated on S129 by endogenous kinases. Interestingly, phosphorylation reduced aSyn toxicity and the percentage of cells with cytosolic inclusions, in comparison to cells expressing mutant forms of aSyn (S129A or S129G) that mimic the unphosphorylated form of aSyn. Using high-resolution 4D imaging and fluorescence recovery after photobleaching (FRAP) in live cells, we compared the dynamics of WT and S129A mutant aSyn. While WT aSyn inclusions were very homogeneous, inclusions formed by S129A aSyn were larger and showed FRAP heterogeneity. Upon blockade of aSyn expression, cells were able to clear the inclusions formed by WT aSyn. However, this process was much slower for the inclusions formed by S129A aSyn. Interestingly, whereas the accumulation of WT aSyn led to a marked induction of autophagy, cells expressing the S129A mutant failed to activate this protein quality control pathway. The finding that the phosphorylation state of aSyn on S129 can alter the ability of cells to clear aSyn inclusions provides important insight into the role that this posttranslational modification may have in the pathogenesis of PD and other synucleinopathies, opening novel avenues for investigating the molecular basis of these disorders and for the development of therapeutic strategies.
Source: PLoS Genetics
Institutions: University of Lisbon, Instituto de Medicina Molecular João Lobo Antunes, University of Wrocław, Universidade Nova de Lisboa, Hebrew University of Jerusalem, Instituto de Biologia Experimental e Tecnológica, Universitätsmedizin Göttingen, Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103, University of Göttingen
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,043
Funders: American Federation for Aging Research, European Commission, Deutsche Forschungsgemeinschaft, German-Israeli Foundation for Scientific Research and Development, Israel Science Foundation, Centre National de la Recherche Scientifique, Fundação para a Ciência e a Tecnologia, FP7 Food, Agriculture and Fisheries, Biotechnology
Awards: DECIPHERING THE ROLE OF ALFA-SYNUCLEIN PHOSPHORYLATION IN PARKINSON’S DISEASE, G6061696303, G6681220715, INVESTIGATING THE NEUROPROTECTIVE EFFECT OF PLANT POLYPHENOLS IN MODELS OF PARKINSON’S DISEASE, G8571247832, Polifenóis como agentes protectores em modelos celulares de alfa-sinucleinopatias, em particular na doença de Parkinson
OpenAlex ID: W2066304458
